Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
Weitzman's equity reduction follows a 57% one-year stock price surge, leaving her with $18.3 million in direct holdings.
Overview
Deborah Weitzman, CEO of the PSS Segment, reported a sale of 7,354 shares of Cardinal Health, Inc. (NYSE:CAH) in a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($235.45); post-transaction value based on the August 18 market close ($234.98).
Details
Cardinal Health is one of the largest healthcare services and products companies globally, with a TTM revenue base of $254.2 billion and a market capitalization of $55.0 billion. The company maintains a competitive advantage through its integrated distribution network, scale across pharmaceutical and medical segments, and established relationships with a broad spectrum of healthcare providers across multiple geographies. With 58,788 employees worldwide, Cardinal Health is positioned as a critical infrastructure provider within the healthcare supply chain, supporting the delivery of care across institutional and individual patient settings.
Source
Originally published at www.fool.com.